Skip to content

Dossier · PTRN · Dormant

PTRN · Pattern Group Inc. Series A · Stock research

Last analysed ·

Current thesis

Post-Russell momentum squeeze in a recent-IPO e-commerce compounder has broken — down ~25% from the $29.80 high to $22 in four sessions on a macro tech rout plus a Bear Cave short report. Fundamentals intact (raised FY guide, 127% NRR) but the tape is now a falling knife into a binary 2026-08-05 Q2 print. No clean entry; let it base.

Invalidation trigger

A daily close below $19 loses the June secondary floor and confirms the post-Russell squeeze is fully unwinding toward the IPO-era $14–15 gap; a 2026-08-05 Q2 print decelerating under ~40% revenue growth or NRR below 120% ends the hypergrowth narrative regardless of price.

Thesis status

Open commitment catalyst 4d agoscored if the trigger above fires How this is scored →

Latest analysis and events for PTRN —

As of 2026-07-26, orbyd's latest analysis for Pattern Group Inc. Series A (PTRN): Post-Russell momentum squeeze in a recent-IPO e-commerce compounder has broken — down ~25% from the $29.80 high to $22 in four sessions on a macro tech rout plus a Bear Cave short report. Fundamentals intact (raised FY guide, 127% NRR) but the tape is now a falling knife into a binary 2026-08-05 Q2 print. No clean entry; let it base.

Invalidation trigger: A daily close below $19 loses the June secondary floor and confirms the post-Russell squeeze is fully unwinding toward the IPO-era $14–15 gap; a 2026-08-05 Q2 print decelerating under ~40% revenue growth or NRR below 120% ends the hypergrowth narrative regardless of price.

Most recent dated event on file: — catalyst 4d ago.

Current Thesis

The post-Russell momentum squeeze in this recent-IPO e-commerce accelerator has broken. That is roughly −25% in four sessions and a clean loss of the $24 shelf that defined the June rally off the $19.00 secondary. The company itself is still compounding — Q1 2026 revenue $774.0M (+43% YoY), record 127% net revenue retention, net income $29.2M, FY guide raised to $3.29–3.33B — but narrative velocity has flipped from up to down, and the tape is a falling knife into a binary 2026-08-05 Q2 print. This is a name to let base, not to catch.

Bullish and bearish views on Pattern Group Inc. Series A

The model's bull view on Pattern Group Inc. Series A (PTRN), in brief: Fundamentals still accelerating. Q1 2026 (reported ~2026-05-06): revenue $774.0M, +43% YoY; net revenue retention a record 127% (from 115%); net income $29.2M — profitable hypergrowth, rare for a sub-1-year IPO. Guidance raised FY2026 guide lifted to $3.29–3.33B revenue and… The bear view: The momentum shelf is gone. Price closed $27.80 on 2026-07-20, then broke to $22.17 by 2026-07-24 — the $24 post-Russell base flagged a week earlier is lost, and the mean-reversion the prior read warned about is underway. The top bull went neutral. Jefferies cut PTRN to Hold on… Both cases follow in full.

Bull Case

  • Fundamentals still accelerating. Q1 2026 (reported ~2026-05-06): revenue $774.0M, +43% YoY; net revenue retention a record 127% (from 115%); net income $29.2M — profitable hypergrowth, rare for a sub-1-year IPO.
  • Guidance raised FY2026 guide lifted to $3.29–3.33B revenue and adjusted EBITDA $199–201M — management leaning into the momentum on the same May print.
  • Buyback as a floor. A $100M Series A repurchase authorization gives the company a tool to defend the tape into weakness (modest against a ~$3.9B cap, but a signal).
  • Product optionality. Pattern Intelligence (Pi), an AI e-commerce execution engine built on ~77 trillion proprietary data points, launched 2026-05-21 — an automation layer on top of the marketplace-management base across Amazon, Walmart, Target, TikTok Shop and JD.com.
  • Coverage still constructive. 9 analysts, 0 sells, Strong Buy consensus; the average 12-month target sits at $24.00 with a $30 high — sell-side has not turned negative even after the pullback.

Bear Case

  • The momentum shelf is gone. Price closed $27.80 on 2026-07-20, then broke to $22.17 by 2026-07-24 — the $24 post-Russell base flagged a week earlier is lost, and the mean-reversion the prior read warned about is underway.
  • The top bull went neutral. Jefferies cut PTRN to Hold on 2026-07-14 (PT raised to $30 from $21) explicitly on valuation with "shares up 150%." When the highest published target flips to Hold, the ceiling is set.
  • A short report is now circulating. A Bear Cave cautious note (~2026-07-22/24) added company-specific selling on top of the macro rout — an overhang that lingers into the print.
  • Distribution overhang persists. Knox Lane's 8M-share secondary priced $19.00 (~2026-06-15/17, company received no proceeds); the pre-IPO holder is a seller, and the $19 print is the next magnet below.
  • Binary into a broken chart. Q2 lands 2026-08-05 after close; a name down 25% with a short report attached has little cushion for a NRR or growth deceleration surprise.
  • Macro-cyclical beta. Marketplace-acceleration revenue tracks consumer spend, ad rates and platform take-rate policy; the 2026-07-21 move showed it trades as a high-multiple growth proxy on risk-off days.

Setup & Price Structure

Last $22.17 (2026-07-24), market cap ~$3.92B, down from ~$4.88B a week earlier. The four-session sequence — $28.11 (07-18) → $27.80 close (07-20) → −5.9% (07-21) → $22.17 (07-24) — is a momentum-unwind, not a shallow pullback. Price has round-tripped back to the average analyst target zone ($24) and now trades below it, with the $19.00 June secondary as the next visible support and the IPO-era $14–15 gap beneath that. The 52-week range is $8.92–$29.80. With a short report live and a binary earnings print seven trading days out, there is no clean long entry here; the constructive setup is a post-print base and a reclaim of the $24 shelf on volume, not a knife-catch into 2026-08-05.

Catalyst Calendar (next 30 days)

  • Ongoing (undated): any Bear Cave follow-up or company rebuttal; sentiment on the short thesis remains a live driver into the print.
  • Ongoing (undated): $100M buyback execution — repurchase activity near the lows would be visible support.
  • Post-print (watch): further secondary/lockup supply near recovery highs given Knox Lane's demonstrated willingness to sell at $19.

Elapsed catalysts

  • ~2026-07-31 (est.): pre-print blackout window opens (~3 trading days before the Q2 report) — the last window to act before binary risk. (passed 9d ago)
  • 2026-08-05 (after market close): Q2 2026 earnings; call ~4:30 p.m. ET. Watch revenue growth vs the ~40%+ trend, NRR vs the 127% record, and whether the raised $3.29–3.33B FY guide holds — the single decisive event. (passed 4d ago)

What Would Change Our Mind

The read turns constructive if PTRN builds a higher low above the $19 secondary, clears and holds the $24 shelf on a strong 2026-08-05 print (revenue growth sustaining ~40%+, NRR holding ≥125%, FY guide reaffirmed or raised), and the Bear Cave thesis fails to gain traction — that sequence re-establishes the momentum leg and warrants a fresh look. The read is confirmed broken if price loses the June secondary floor: a daily close below $19 opens the IPO-range gap and signals the passive-flow squeeze has fully unwound. A Q2 print decelerating under ~40% revenue growth or NRR below 120% would end the hypergrowth narrative regardless of price.

Correlation Notes

PTRN now trades as a high-multiple growth proxy — the 2026-07-21 drop tracked the broad tech/software selloff on US–Iran risk-off and rising oil, not company news. Beyond macro beta, it is levered to consumer-discretionary spend and marketplace GMV across Amazon, Walmart, Target, TikTok Shop and JD.com, so an Amazon take-rate or platform-fee change hits the whole model. As a recent Russell 2000/3000 addition (effective 2026-06-26) with a tight post-IPO float, it carries amplified small-cap passive-flow beta in both directions — the same mechanic that drove the June squeeze is now working in reverse.

Notes

  • Knox Lane (pre-IPO PE holder) secondary priced $19.00 on 2026-06-17; watch for further lockup/secondary supply near the highs.
  • IPO 2025-09-19 at $14; 52-week range $8.92–$29.00; market cap $4.88B. Recent-IPO float dynamics amplify both squeeze and unwind.
  • Q2 2026 earnings 2026-08-05 after market close — binary; pre-print blackout ~3 trading days prior (est. 2026-07-31).
  • Jefferies cut to Hold on 2026-07-14 (PT $30, up from $21) citing valuation with shares +150% — the highest published target is now neutral. Avg PT $24, 9 analysts, 0 sells.
  • Knox Lane 8M-share secondary priced $19.00 (~2026-06-15/17, no company proceeds); $19 is the next support magnet and a demonstrated seller level.
  • Fundamentals intact: Q1'26 rev $774.0M (+43% YoY), record 127% NRR, net income $29.2M; FY26 guide raised to $3.29-3.33B rev / $199-201M adj EBITDA; $100M buyback authorized; Pattern Intelligence (Pi) AI engine launched 2026-05-21.
  • IPO 2025-09-19 at $14 (day-one close $15.63); 52-wk range $8.92-$29.80; Russell 2000/3000 inclusion effective 2026-06-26 — tight post-IPO float amplifies squeeze and unwind.

Related · shared themes

HUM

Humana Inc.

Post-print floor held: the 2026-08-05 undercut to $353.69 closed green on CVS's Aetna guide raise, and 2026-08-07 closed $385.00 (+4.84%), back above the 50-day of $374.23 and the highest close since 07-28. Morgan Stanley's 08-05 upgrade retired the $249 bear target, but the ≥3% 2028 MA margin claim stays unquantified for 2027 and no company-dated financial event is confirmed inside 30 days.

MEDIUM

RXO

RXO, Inc.

Freight-cycle recovery intact; sell-side has fully caught up into a $20–35 battleground — bears $20 (Goldman 07-16, Susquehanna 07-14), bulls $30–35 (BMO $35 initiation 07-14, Stifel/Truist/Citi $30). Narrative matured from mispriced to consensus; the ~2026-08-05 Q2 print (adj EBITDA guide $27–37M vs $6M Q1) is the binary the whole re-rate discounts.

MEDIUM

CNC

Centene Corporation

Post-print recovery extended: $65.77 close on 2026-08-07 (+2.45%), above the 20-day and 50-day levels marked on 08-04, with the $69.36 52-week high in view. Two dated events inside four sessions — CMS's 3:00pm EDT 2026-08-12 PY2027 rate lock (HealthCare.gov states only; SBE states run to 10-15) and the 08-13 $500M par redemption. Theme still SATURATED: eight post-print target raises, zero cuts, consensus $71.67 scored at 8.97% upside.

LOW

HNGE

Hinge Health, Inc.

Digital-MSK profitability re-rate broke out in May and was pushed into open price discovery by the 2026-06-09 mid-quarter raise (Q2 to $200–202M, +45%; FY26 to $818–824M). But nine sell-side target hikes in two weeks plus accelerating insider selling mark a late, distribution-prone phase, with no company catalyst until the ~2026-08-04 Q2 print.

LOW

See also · stocks to watch